| |
| |
|
| Insider
Information: |
Czirr James C |
| Relationship: |
10% Owner |
| City: |
Sandpoint |
| State: |
ID |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,168,940 |
|
|
Indirect Shares
|
5,922,207 |
|
|
| Direct
Value |
$16,039,244 |
|
|
|
Indirect Value
|
$15,397,738 |
|
|
| Total
Shares |
12,091,147 |
|
|
| Total
Value |
$31,436,982 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -84.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
10% Owner |
2022-07-22 |
6,168,940 |
2024-04-23 |
5,922,207 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-10-04 |
4 |
AS |
$3.62 |
$36,200 |
D/D |
(10,000) |
6,228,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-11-01 |
4 |
AS |
$3.19 |
$31,900 |
D/D |
(10,000) |
6,208,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-12-02 |
4 |
AS |
$2.37 |
$23,700 |
D/D |
(10,000) |
6,198,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2022-01-11 |
4 |
AS |
$2.10 |
$21,000 |
D/D |
(10,000) |
6,188,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2022-02-02 |
4 |
AS |
$2.10 |
$21,000 |
D/D |
(10,000) |
6,178,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2022-07-22 |
4 |
AS |
$2.09 |
$20,870 |
D/D |
(10,000) |
6,168,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2013-11-15 |
4 |
B |
$6.90 |
$6,897 |
D/D |
1,000 |
844,450 |
2.81 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2015-01-31 |
4 |
D |
$3.22 |
$300,001 |
D/D |
(93,168) |
883,630 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2016-09-30 |
4/A |
D |
$1.13 |
$856,418 |
I/I |
(757,892) |
2,711,918 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2016-10-13 |
4 |
D |
$1.13 |
$259,203 |
I/I |
(229,383) |
3,196,115 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2016-11-10 |
4 |
D |
$0.78 |
$20,872 |
I/I |
(26,759) |
3,169,356 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-05-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(67,515) |
6,441,786 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-07-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(306) |
6,441,480 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-08-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,690) |
6,402,790 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
• • • |
2003-10-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,100 |
31,100 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2003-12-30 |
5 |
GA |
$0.00 |
$0 |
I/I |
100,000 |
100,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2004-12-20 |
5 |
GA |
$0.00 |
$0 |
I/I |
120,000 |
29,400 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2005-12-27 |
5 |
GA |
$0.00 |
$0 |
I/I |
187,000 |
390,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-08-29 |
5 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
66,400 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2007-12-28 |
5/A |
GA |
$0.00 |
$0 |
I/I |
198,000 |
616,200 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2007-12-28 |
5 |
GA |
$0.00 |
$0 |
I/I |
198,000 |
588,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
• • • |
2003-10-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,100 |
4,854,768 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2003-12-30 |
5 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
4,679,768 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2004-12-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
131,000 |
4,548,768 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2005-08-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,500 |
0 |
0 |
- |
|
107 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
